Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Net Margin (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Net Margin for 2 consecutive years, with 107500.0% as the latest value for Q3 2025.

  • Quarterly Net Margin fell 10644372.0% to 107500.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 86687.5% through Dec 2025, down 8662747.0% year-over-year, with the annual reading at 86687.5% for FY2025, 8662747.0% down from the prior year.
  • Net Margin hit 107500.0% in Q3 2025 for Connect Biopharma Holdings, down from 26872.92% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 61.56% in Q2 2024 to a low of 107500.0% in Q3 2025.